BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3094043)

  • 21. Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins.
    Parente L; Di Rosea M; Flower RJ; Ghiara P; Meli R; Persico P; Salmon JA; Wood JN
    Eur J Pharmacol; 1984 Mar; 99(2-3):233-9. PubMed ID: 6428924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current.
    Schweitzer P; Madamba S; Siggins GR
    Nature; 1990 Aug; 346(6283):464-7. PubMed ID: 1974033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase.
    Gupta OP; Sing S; Bani S; Sharma N; Malhotra S; Gupta BD; Banerjee SK; Handa SS
    Phytomedicine; 2000 Mar; 7(1):21-4. PubMed ID: 10782486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipase A2 activity in carrageenin-induced inflammatory tissue of rats.
    Ohuchi K; Watanabe M; Numajiri N; Tsurufuji S
    Biochem Pharmacol; 1982 Sep; 31(18):2993-8. PubMed ID: 6814450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Manoalide: a new phospholipase A2 inhibitor of marine origin with potential immunoregulatory effect].
    Mayer AM
    Medicina (B Aires); 1989; 49(2):175-80. PubMed ID: 2640487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy.
    Tanaka K; Kato T; Matsumoto K; Yoshida T
    Inflammation; 1993 Apr; 17(2):107-19. PubMed ID: 8491510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacology of arachidonic acid-induced rat paw edema.
    DiMartino MJ; Campbell GK; Wolff CE; Hanna N
    Agents Actions; 1987 Aug; 21(3-4):303-5. PubMed ID: 3120509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of insulin release due to inhibition of phospholipase A2 activity.
    Tanaka N; Kagawa S; Murakoso K; Shimizu S; Matsuoka A
    Horm Metab Res; 1983 May; 15(5):255-6. PubMed ID: 6409772
    [No Abstract]   [Full Text] [Related]  

  • 31. Carrageenan-stimulated release of arachidonic acid and of lactate dehydrogenase from rat pleural cells.
    Lo TN; Saul WF; Lau SS
    Biochem Pharmacol; 1987 Jul; 36(14):2405-13. PubMed ID: 3111482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the arachidonic acid cascade--I. Inhibition of phospholipase A2 in vitro and in vivo by several novel series of inhibitor compounds.
    Wallach DP; Brown VJ
    Biochem Pharmacol; 1981 Jun; 30(11):1315-24. PubMed ID: 7271829
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibition of arachidonic acid-induced ear edema in the mouse with lipoxygenase-, cyclo-oxygenase- and dual inhibitors].
    Zarnack S; Bekemeier H; Giessler AJ
    Pharmazie; 1988 May; 43(5):337-8. PubMed ID: 3140256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipase A2-induced rat mast cell secretion. Role of arachidonic acid metabolites.
    Chi EY; Henderson WR; Klebanoff SJ
    Lab Invest; 1982 Dec; 47(6):579-85. PubMed ID: 6815379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism.
    Fischer SM; Mills GD; Slaga TJ
    Carcinogenesis; 1982; 3(11):1243-5. PubMed ID: 7151243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavonoids and arachidonic acid metabolism.
    Welton AF; Hurley J; Will P
    Prog Clin Biol Res; 1988; 280():301-12. PubMed ID: 2845434
    [No Abstract]   [Full Text] [Related]  

  • 39. Intracerebroventricular injection of phospholipases A2 inhibitors modulates allodynia after facial carrageenan injection in mice.
    Yeo JF; Ong WY; Ling SF; Farooqui AA
    Pain; 2004 Nov; 112(1-2):148-55. PubMed ID: 15494195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of a role for phospholipase A2 and arachidonic acid metabolism in human lymphocyte natural cytotoxicity.
    Carine K; Hudig D
    Cell Immunol; 1984 Aug; 87(1):270-83. PubMed ID: 6430571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.